 |
PDBsum entry 2asu
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
FEBS J
272:5799-5807
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the beta-chain of human hepatocyte growth factor-like/macrophage stimulating protein.
|
|
F.Carafoli,
D.Y.Chirgadze,
T.L.Blundell,
E.Gherardi.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Hepatocyte growth factor like/macrophage stimulating protein (HGFl/MSP) and
hepatocyte growth factor/scatter factor (HGF/SF) define a distinct family of
vertebrate-specific growth factors structurally related to the blood proteinase
precursor plasminogen and with important roles in development and cancer.
Although the two proteins share a similar domain structure and mechanism of
activation, there are differences between HGFl/MSP and HGF/SF in terms of the
contribution of individual domains to receptor binding. Here we present a
crystal structure of the 30 kDa beta-chain of human HGFl/MSP, a serine
proteinase homology domain containing the high-affinity binding site for the RON
receptor. The structure describes at 1.85 Angstrom resolution the region of the
domain corresponding to the receptor binding site recently defined in the HGF/SF
beta-chain, namely the central cleft harboring the three residues corresponding
to the catalytic ones of active proteinases (numbers in brackets define the
sequence position according to the standard chymotrypsinogen numbering system)
and an adjacent loop flanking
the S1 specificity pocket and containing residues Asn682 (c217) and Arg683
(c218) previously shown to be essential for binding of HGFl/MSP to the RON
receptor. The study confirms the concept that the serine proteinase homology
domains of HGFl/MSP and HGF/SF bind their receptors in an 'enzyme-substrate'
mode, reflecting the common evolutionary origin of the plasminogen-related
growth factors and the proteinases of the clotting and fibrinolytic pathways.
However, analysis of the intermolecular interactions in the crystal lattice of
beta-chain HGFl/MSP fails to show the same contacts seen in the HGF/SF
structures and does not support a conserved mode of dimerization of the serine
proteinase homology domains of HGFl/MSP and HGF/SF responsible for receptor
activation.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. (A) Ribbon diagram of the -chain of
HGFl/MSP. The three residues replacing the catalytic triad of
active proteinases: Q522 (c57), Q568 (c102) and Y661 (c195) are
shown as solid sticks. Also shown are the five intradomain
disulfide bonds while a sixth disulfide connecting the - and -chains
[Cys468-Cys588 (c122)] is not shown in the figure. L4, L5, L8,
10, L11 and L13 define loops discussed in the text and detailed
in Fig. 2A. (B) Detailed view of the active site region of the
-chain of
HGFl/MSP. The three residues corresponding to the catalytic ones
of actives serine proteinases are shown in red; residues
corresponding to the S1 specificity pocket (L11) are shown in
blue; a segment of the L13 loop is shown in yellow. The
disulfide bond between C657 and C685 (c191-c220) is also shown.
The figure was generated with PYMOL[36] and SPOCK
(http://quorum.tamu.edu/Manual/).
|
 |
Figure 3.
Fig. 3. (A) Structural alignment of a model of the
single-chain, precursor form of the serine proteinase homology
domain of HGFl/MSP (green) and the crystal structure of the
corresponding two-chain form (pink). The model of the single
chain form of the protein was constructed with MODELLER[39],
using the atomic coordinates of the plasminogen -chain (pdb:
1QRZ) [24] as template. Residues discussed in the text are
labeled and shown as solid sticks. The figure was generated with
PYMOL [36]. (B) and (C) Surface representation of the serine
proteinase domains of two-chain HGFl/MSP (b) and the model of
single-chain HGFl/MSP (c). The amino acids shown in colour are
either those corresponding to the catalytic triad (on the left)
or amino acids in L13 that have been shown by mutagenesis to be
involved in receptor binding. The figure has been prepared with
SPOCK (http://quorum.tamu.edu/Manual/).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the Federation of European Biochemical Societies:
FEBS J
(2005,
272,
5799-5807)
copyright 2005.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
G.V.Freue,
M.Sasaki,
A.Meredith,
O.P.Günther,
A.Bergman,
M.Takhar,
A.Mui,
R.F.Balshaw,
R.T.Ng,
N.Opushneva,
Z.Hollander,
G.Li,
C.H.Borchers,
J.Wilson-McManus,
B.M.McManus,
P.A.Keown,
and
W.R.McMaster
(2010).
Proteomic signatures in plasma during early acute renal allograft rejection.
|
| |
Mol Cell Proteomics,
9,
1954-1967.
|
 |
|
|
|
|
 |
H.R.Maun,
D.Kirchhofer,
and
R.A.Lazarus
(2010).
Pseudo-active sites of protease domains: HGF/Met and Sonic hedgehog signaling in cancer.
|
| |
Biol Chem,
391,
881-892.
|
 |
|
|
|
|
 |
R.Ganesan,
C.Eigenbrot,
and
D.Kirchhofer
(2010).
Structural and mechanistic insight into how antibodies inhibit serine proteases.
|
| |
Biochem J,
430,
179-189.
|
 |
|
|
|
|
 |
R.M.Thomas,
D.V.Jaquish,
R.P.French,
and
A.M.Lowy
(2010).
The RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells.
|
| |
Pancreas,
39,
301-307.
|
 |
|
|
|
|
 |
M.Benvenuti,
and
S.Mangani
(2007).
Crystallization of soluble proteins in vapor diffusion for x-ray crystallography.
|
| |
Nat Protoc,
2,
1633-1651.
|
 |
|
|
|
|
 |
M.H.Wang,
H.P.Yao,
and
Y.Q.Zhou
(2006).
Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
|
| |
Acta Pharmacol Sin,
27,
641-650.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |